Victory Capital Management Inc Cidara Therapeutics, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.39 - $4.0 $12,992 - $21,744	-5,436 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$1.74 - $4.26 $2,023 - $4,954	1,163 Added 27.22%	5,436 $13,000
Q4 2019 Feb 04, 2020	BUY	$1.77 - $3.84 $1,407 - $3,052	795 Added 22.86%	4,273 $13,000
Q3 2019 Nov 12, 2019	BUY	$1.25 - $2.35 $4,347 - $8,173	3,478 New	3,478 $7,000
Q2 2019 Aug 15, 2019	SELL	$1.49 - $2.94 $3,786 - $7,470	-2,541 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$3.7 - $5.25 $1,235 - $1,753	334 Added 15.13%	2,541 $11,000
Q2 2017 Aug 07, 2017	BUY	N/A	2,207	2,207 $17,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.